lithium has been researched along with Parkinson Disease in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (60.98) | 18.7374 |
| 1990's | 3 (7.32) | 18.2507 |
| 2000's | 1 (2.44) | 29.6817 |
| 2010's | 5 (12.20) | 24.3611 |
| 2020's | 7 (17.07) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, KS; Ayyadurai, N; G, S; Giridharan, B; Gopalakrishnan, AV; Kumar, N; Mahalaxmi, I; Nachimuthu, SK; Narayanasamy, A; P, S; Pasha, MY; Rao, KRSS; Reddy, JK; Selvaraj, P; Suriyanarayanan, A; Vellingiri, B; Venkatesan, D; Winster, H | 1 |
| Nabekura, T; Uwai, Y | 1 |
| Backlund, L; Gissler, M; Lavebratt, C; Millischer, V; Ponzer, K; Schalling, M | 1 |
| Abdelaty, AO; Abdelrahman, AI; Aboul Ezz, HS; Ahmed, NA; Ebrahim, YM; El-Feky, AS; Elgohary, A; Elsaeed, H; Fahmy, HM; Ismail, HA; Khadrawy, YA; Mohammed, FF; Mohammed, HS; Noor, NA; Radwan, NM; Sakraan, A; Tharwat, EK | 1 |
| Kimura, T; Kuroda, K; Ota, T; Suzuki, Y; Yoshida, K | 1 |
| Guttuso, T | 1 |
| Kawada, T | 1 |
| Lecarpentier, Y; Vallée, A; Vallée, JN | 1 |
| De Blanco, MT; Guttuso, T; Ramanathan, M; Russak, E | 1 |
| Bhattacharjee, S; Chadwick, G; Yela, R | 1 |
| Andersen, JK; Batir, S; Chinta, SJ; Dewey, CM; Kim, YH; Lieu, CA; Rajagopalan, S; Rane, A | 1 |
| Ding, H; Fan, Z; Ke, ZJ; Luo, J; Yong, Y | 1 |
| Fann, JR | 1 |
| Lang, AE | 2 |
| Yung, CY | 1 |
| Coffey, CE; Massey, EW; Olanow, CW; Ross, DR | 1 |
| Zaleska, B | 1 |
| Fahn, S; Reches, A | 1 |
| Coffey, CE; Ferren, EL; Olanow, CW; Ross, DR; Walker, JI | 1 |
| Coffey, CE; Ferren, EL; Olanow, CW; Ross, DR; Sullivan, JL | 1 |
| Bragdon, AC; Coffey, CE; Ferren, EL; Hurwitz, BJ; Olanow, CW; Ross, DR | 1 |
| Colucci d'Amato, C; De Angelis, G; Giordano, L; Iaccarino, C; Marmo, E; Mastrosimone, F | 1 |
| Gopinathan, G; Lieberman, A | 1 |
| Furno, A; Mancinella, A | 1 |
| Ghose, K; Lecamwasam, D; Moyles, K; Synek, B | 1 |
| Benbow, C; Perry, W; Rockwell, E; West, L | 1 |
| Prange, AJ | 1 |
| Gabriel, E; Karobath, M; Lenz, G | 1 |
| Merskey, H | 1 |
| Braden, W | 1 |
| Marsden, CD; Quinn, N | 1 |
| Dilsaver, SC; Jaeckle, RS | 1 |
| Ambani, LM; Van Woert, MH | 1 |
| Dalén, P; Steg, G | 1 |
| McCaul, JA; Stern, GM | 1 |
| Floru, L | 1 |
| Chazot, G; Courjon, J; Moene, Y; Setiey, A; Trillet, M | 1 |
| Bora, SS; Radichevich, I; Werner, SC | 1 |
| Pearlman, CA | 1 |
| Ryback, RS; Schwab, RS | 1 |
8 review(s) available for lithium and Parkinson Disease
| Article | Year |
|---|---|
Role of heavy metals (copper (Cu), arsenic (As), cadmium (Cd), iron (Fe) and lithium (Li)) induced neurotoxicity.
Topics: Arsenic; Cadmium; Copper; Humans; Iron; Lithium; Metals, Heavy; Neurotoxicity Syndromes; Parkinson Disease | 2022 |
High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity.
Topics: alpha-Synuclein; Alzheimer Disease; Autophagy; beta Catenin; beta-Glucosidase; Brain Chemistry; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3 beta; Humans; Incidence; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Lithium; Lithium Carbonate; Melanoma; Models, Biological; Mutation; Neuroprotective Agents; Nicotiana; Nuclear Receptor Subfamily 4, Group A, Member 2; Parkinson Disease; Parkinsonian Disorders; Smokers; Water; Wnt Signaling Pathway | 2019 |
Parkinson's Disease: Potential Actions of Lithium by Targeting the WNT/β-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway.
Topics: Animals; Glutamates; Humans; Inflammation; Lithium; Oxidative Stress; Parkinson Disease; Wnt Signaling Pathway | 2021 |
Neurological effects of psychopharmacological agents.
Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; Bundle-Branch Block; Delirium; Depressive Disorder; Humans; Lithium; Male; Nervous System Diseases; Parkinson Disease; Psychotropic Drugs; Selegiline | 2002 |
A review of clinical trials of lithium in neurology.
Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis | 1984 |
[Progress in the treatment of degenerative diseases of the nervous system. Selected problems].
Topics: Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Humans; Huntington Disease; Lithium; Neostigmine; Parkinson Disease; Penicillamine; Phthalazines; Selegiline; Tetrabenazine; Tiapamil Hydrochloride | 1980 |
Novel uses of thyroid hormones in patients with affective disorders.
Topics: Antidepressive Agents; Bipolar Disorder; Electroconvulsive Therapy; Female; Humans; Levodopa; Lithium; Male; Mood Disorders; Parkinson Disease; Thyroid Diseases; Thyroid Gland; Thyroid Hormones | 1996 |
Neurology and psychopharmacology.
Topics: Analgesia; Depression; Humans; Huntington Disease; Hysteria; Lithium; Movement Disorders; Parkinson Disease; Parkinson Disease, Secondary; Phenothiazines; Psychopharmacology; Psychotic Disorders; Psychotropic Drugs; Schizophrenia; Thioxanthenes | 1975 |
7 trial(s) available for lithium and Parkinson Disease
| Article | Year |
|---|---|
A review of clinical trials of lithium in neurology.
Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis | 1984 |
Dyskinesias associated with lithium therapy in parkinsonism.
Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Lithium; Male; Middle Aged; Parkinson Disease; Random Allocation | 1984 |
Treatment of the "on-off" phenomenon in Parkinsonism with lithium carbonate.
Topics: Adult; Aged; Female; Humans; Lithium; Lithium Carbonate; Male; Middle Aged; Parkinson Disease; Placebos; Time Factors | 1982 |
Lithium for painful dystonia in Parkinson's disease.
Topics: Adult; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Dystonia; Humans; Lithium; Lithium Carbonate; Middle Aged; Pain, Intractable; Parkinson Disease | 1986 |
Letter: Lithium in Parkinson's disease.
Topics: Carbonates; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Antagonism; Drug Evaluation; Drug Therapy, Combination; Humans; Lithium; Movement Disorders; Parkinson Disease | 1974 |
[Clinical treatment of lithium induced tremors with a beta receptor antagonist (propranolol)].
Topics: Adjustment Disorders; Adrenergic beta-Antagonists; Bipolar Disorder; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Handwriting; Humans; Lithium; Motor Skills; Parkinson Disease; Propranolol; Tremor | 1971 |
Artifactual elevation of PBI from an iodinated dye used to stain medicinal capsules pink.
Topics: Bipolar Disorder; Blood Proteins; Capsules; Carbonates; Chromatography, Paper; Clinical Trials as Topic; Dihydroxyphenylalanine; Diiodotyrosine; Fluoresceins; Humans; Iodine; Iodoproteins; Lithium; Monoiodotyrosine; Parkinson Disease; Protein Binding; Thyroxine; Triiodothyronine | 1969 |
27 other study(ies) available for lithium and Parkinson Disease
| Article | Year |
|---|---|
Relationship between lithium carbonate and the risk of Parkinson-like events in patients with bipolar disorders: A multivariate analysis using the Japanese adverse drug event report database.
Topics: Antimanic Agents; Bipolar Disorder; Drug-Related Side Effects and Adverse Reactions; Humans; Japan; Lithium; Lithium Carbonate; Middle Aged; Multivariate Analysis; Parkinson Disease; Valproic Acid | 2022 |
Lithium and risk of cardiovascular disease, dementia and venous thromboembolism.
Topics: Bipolar Disorder; Cardiovascular Diseases; Dementia; Humans; Lithium; Lithium Compounds; Parkinson Disease; Venous Thromboembolism | 2023 |
Evaluation of the therapeutic potential of cerebrolysin and/or lithium in the male Wistar rat model of Parkinson's disease induced by reserpine.
Topics: Acetylcholinesterase; Animals; Disease Models, Animal; Lithium; Male; Neurodegenerative Diseases; Parkinson Disease; Rats; Rats, Wistar; Reserpine | 2023 |
[A case of lithium intoxication with reversible parkinsonism].
Topics: Adult; Aged; Bipolar Disorder; Humans; Lithium; Male; Parkinson Disease | 2023 |
High lithium levels in tobacco, incidences of Parkinson's disease and melanoma: Mechanism of the association.
Topics: Humans; Incidence; Lithium; Melanoma; Nicotiana; Parkinson Disease | 2020 |
Could high lithium levels in tobacco contribute to reduced risk of Parkinson's disease in smokers?
Topics: Humans; Lithium; Nicotiana; Parkinson Disease; Protective Factors; Smokers; Smoking | 2019 |
Can lithium unmask the preclinical Parkinsonian features?
Topics: Aged; Antipsychotic Agents; Biomarkers; Bipolar Disorder; Corpus Striatum; Diagnosis, Differential; Dopamine; Humans; Lithium; Male; Parkinson Disease; Parkinson Disease, Secondary; Putamen; Radiography | 2013 |
Lithium prevents parkinsonian behavioral and striatal phenotypes in an aged parkin mutant transgenic mouse model.
Topics: Aging; Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine; Lithium; Mice, Transgenic; Motor Activity; Neostriatum; Neuroprotective Agents; Parkinson Disease; Substantia Nigra | 2014 |
Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson's disease.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dopamine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lithium; Male; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Sympatholytics | 2011 |
Treatment of Parkinson's disease with agents other than levodopa and dopamine agonists: controversies and new approaches.
Topics: Adrenergic beta-Antagonists; Amantadine; Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Dopamine; Dopamine Antagonists; Humans; Lithium; Neurology; Parasympatholytics; Parasympathomimetics; Parkinson Disease; Selegiline; Serotonin; Sympathomimetics | 1984 |
Lithium in the "on-off" phenomenon.
Topics: Humans; Lithium; Parkinson Disease; Receptors, Dopamine | 1983 |
Lithium and parkinsonism.
Topics: Aged; Female; Humans; Lithium; Parkinson Disease | 1984 |
"On-off" syndrome treated with lithium carbonate: a case report.
Topics: Adult; Athetosis; Chorea; Humans; Levodopa; Lithium; Lithium Carbonate; Male; Parkinson Disease; Receptors, Dopamine | 1981 |
The effect of lithium on the "on-off" phenomenon in parkinsonism.
Topics: Adult; Double-Blind Method; Female; Humans; Levodopa; Lithium; Male; Middle Aged; Movement Disorders; Parkinson Disease; Random Allocation | 1983 |
Personal experience with a combination of drugs in subjects with dopa resistant Parkinson's disease.
Topics: Amantadine; Amitriptyline; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Hyperkinesis; Levodopa; Lithium; Middle Aged; Parkinson Disease; Trazodone | 1980 |
Treatment of "on-off" phenomena with lithium.
Topics: Female; Humans; Lithium; Male; Middle Aged; Parkinson Disease | 1982 |
[Lithium: biochemical aspects, physiological action, clinical use, therapeutic outlook].
Topics: Bipolar Disorder; Bone Marrow Diseases; Female; Humans; Hyperthyroidism; Inappropriate ADH Syndrome; Lactation; Lithium; Parkinson Disease; Pregnancy; Tissue Distribution | 1981 |
Chronic lithium neurotoxicity presenting as Parkinson's disease.
Topics: Aged; Diagnosis, Differential; Humans; Lithium; Male; Nervous System Diseases; Parkinson Disease | 1994 |
Sleep deprivation in an elderly man with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Depressive Disorder; Humans; Lithium; Male; Parkinson Disease; Sleep Deprivation | 1993 |
[The extrapyramidal symptoms in the combination of lithium long-term lithium therapy with nortriptyline. A case report on the formation of a pathogenesis hypothesis].
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Chlorprothixene; Clopenthixol; Dibenzazepines; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lithium; Long-Term Care; Nortriptyline; Parkinson Disease; Parkinson Disease, Secondary; Procyclidine; Propranolol; Synapses; Thioridazine | 1976 |
Response to lithium in a case of L-dopa-induced psychosis.
Topics: Humans; Levodopa; Lithium; Male; Middle Aged; Parkinson Disease; Personality; Psychoses, Substance-Induced | 1977 |
Covariation of depressive symptoms, parkinsonism, and post-dexamethasone plasma cortisol levels in a bipolar patient: simultaneous response to ECT and lithium carbonate.
Topics: Bipolar Disorder; Brain; Dexamethasone; Electroconvulsive Therapy; Female; Humans; Hydrocortisone; Lithium; Lithium Carbonate; Middle Aged; Neurotransmitter Agents; Parkinson Disease | 1986 |
Lithium and levodopa in parkinsonism.
Topics: Dihydroxyphenylalanine; Humans; Lithium; Parkinson Disease | 1973 |
Lithium and levodopa in parkinsonism.
Topics: Dihydroxyphenylalanine; Female; Humans; Hyperkinesis; Lithium; Male; Parkinson Disease | 1973 |
[Unusual clinical and electroencephalographic aspects induced by lithium-dopa association].
Topics: Aged; Brain; Cognition Disorders; Coma; Dihydroxyphenylalanine; Electroencephalography; Female; Humans; Lithium; Myoclonus; Parkinson Disease | 1972 |
Manic behavior and levodopa.
Topics: Bipolar Disorder; Dihydroxyphenylalanine; Humans; Lithium; Male; Middle Aged; Parkinson Disease | 1971 |
Manic response to levodopa therapy. Report of a case.
Topics: Aged; Bipolar Disorder; Dihydroxyphenylalanine; Humans; Lithium; Male; Parkinson Disease; Psychoses, Substance-Induced | 1971 |